{"database": "lobbying", "table": "lobbying_activities", "rows": [[1199739, "c7863ce6-f326-41ad-a272-893a51b513c9", "Q4", "THE UNITED STATES PHARMACOPEIAL CONVENTION", 400358632, "THE UNITED STATES PHARMACOPEIAL CONVENTION", 2011, "fourth_quarter", "PHA", "- Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients.\n- Implementation of the Food Safety Modernization Act.\n- Issues regarding creating and updating monographs. - Issues regarding FDA funding.\n- S 1584, \"Drug Safety Accountability Act of 2011\", regarding advice on drug quality.\n- HR 1483, \"Drug Safety Enhancement Act of 2011\", regarding advice on drug quality.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)", null, 60000, 0, 0, "2012-01-19T19:10:32.827000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1199739"], "units": {}, "query_ms": 1.3012511190026999, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}